2.15
price down icon6.11%   -0.14
pre-market  Vorhandelsmarkt:  2.15  
loading

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

pulisher
Nov 20, 2024

Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register

Nov 19, 2024
pulisher
Nov 18, 2024

Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 16, 2024

Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail

Nov 16, 2024
pulisher
Nov 15, 2024

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews

Nov 15, 2024
pulisher
Nov 15, 2024

SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 14, 2024

Calidi prices 4.4M shares at $1.69 in public offering - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Calidi announces common stock offering, no amount given - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics plans stock offering - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics plans stock offering By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Advances with FDA Clearance and Funding - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 04, 2024

Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle

Nov 04, 2024
pulisher
Nov 02, 2024

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 29, 2024

Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart

Oct 29, 2024
pulisher
Oct 25, 2024

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 25, 2024
pulisher
Oct 24, 2024

Calidi to present data supporting RTNova at upcoming conferences - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics secures $2 million in equity financing - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times

Oct 23, 2024
pulisher
Oct 19, 2024

Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance

Oct 19, 2024
pulisher
Oct 19, 2024

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times

Oct 19, 2024
pulisher
Oct 18, 2024

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 18, 2024
pulisher
Oct 17, 2024

Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

Cocoa #7 (CAU21) Quote - The Globe and Mail

Oct 16, 2024
pulisher
Oct 13, 2024

Wendy Pizarro - Los Angeles Times

Oct 13, 2024
pulisher
Oct 11, 2024

CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada

Oct 11, 2024
pulisher
Oct 04, 2024

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Oct 04, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian

Sep 30, 2024
pulisher
Sep 24, 2024

Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com

Sep 24, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):